{"id":"W3088330245","doi":"10.1016/j.annonc.2020.08.884","title":"625P Pembrolizumab (pembro) plus enzalutamide (enza) in patients with abiraterone acetate (abi)-pretreated metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 Cohort C update","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"Western University","funders":"Merck Sharp and Dohme","keywords":"Medicine; Enzalutamide; Prostate cancer; Cohort; Abiraterone acetate; Internal medicine; Abiraterone; Cancer; Urology; Oncology; Surgery; Androgen deprivation therapy; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002484327,0.0005093004,0.001323324,0.0006647247,0.0002050573,0.001041292,0.0008903396,0.0004913326,0.004787471],"category_scores_gemma":[0.003222962,0.0002747591,0.001600672,0.001483857,0.0001936255,0.0008450078,0.0005677579,0.001572316,0.001171334],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001825267,"about_ca_system_score_gemma":0.002454286,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01033042,"about_ca_topic_score_gemma":0.03901971,"domain_scores_codex":[0.999477,0.000125884,0.0000889595,0.0000810889,0.0001692722,0.00005775631],"domain_scores_gemma":[0.9986458,0.0004204447,0.0004250273,0.00005832236,0.0002827978,0.0001677122],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.01106735,0.0003868123,0.01415177,0.008138716,0.003689614,0.00008591889,0.00008970848,0.001087644,0.001448862,0.0007007736,0.1577947,0.8013581],"study_design_scores_gemma":[0.02628357,0.006227169,0.134601,0.0139754,0.01930794,0.001289561,0.0001962739,0.001043834,0.001407454,0.002050678,0.7934529,0.0001642814],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.0857494,0.7644005,0.002328861,0.01690252,0.004020847,0.00129968,0.07913446,0.0004322239,0.04573151],"genre_scores_gemma":[0.1822774,0.7004607,0.007872839,0.01778614,0.003430467,0.001542113,0.07688801,0.0002427847,0.009499518],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.01033042,"threshold_uncertainty_score":0.0205406,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06414097661310898,"score_gpt":0.3659130848340182,"score_spread":0.3017721082209092,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}